Vikas Suri
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
- Hematology 15
- Chronic Myeloid Leukemia Treatments 6
- Acute Myeloid Leukemia Research 4
-
- COVID-19 Clinical Research Studies 13
- Viral Infections and Vectors 4
- Co-authors
- Goverdhan Dutt PuriLakshmi Narayana YaddanapudiAshu RastogiPankaj MalhotraNaresh SachdevaAnil BhansaliSandeep GroverSavita Kumari
- Journals
- Asian Journal of Psychiatry (4 papers)The Indian Journal of Medical Research (3 papers)QJM (3 papers)Frontiers in Medicine (2 papers)Blood (1 paper)
- Partner nations
- IndiaUnited States
In The Last Decade
Vikas Suri
65 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 118
- Infectious Diseases 367
- Neurology 263
- Applied Microbiology and Biotechnology 29
- Critical Care and Intensive Care Medicine 66
- Pathology and Forensic Medicine 228
Countries citing papers authored by Vikas Suri
This map shows the geographic impact of Vikas Suri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas Suri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas Suri more than expected).
Fields of papers citing papers by Vikas Suri
This network shows the impact of papers produced by Vikas Suri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas Suri. The network helps show where Vikas Suri may publish in the future.
Co-authors
The 25 scholars most cited alongside Vikas Suri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 34 | |
| 4 | 2021 | 3 | |
| 5 | 2021 | 40 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 12 | |
| 9 | 2020 | 5 | |
| 10 | 2019 | 2 | |
| 11 | 2017 | 6 | |
| 12 | 2016 | 9 | |
| 13 | 2016 | 42 | |
| 14 | 2015 | 21 | |
| 15 | 2015 | 14 | |
| 16 | 2014 | 7 | |
| 17 | 2014 | 1 | |
| 18 | 2009 | 13 | |
| 19 | 2009 | 5 | |
| 20 | 2009 | 24 |
About Vikas Suri
Vikas Suri is a scholar working on Hematology, Infectious Diseases, Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine and Parasitology, having authored 69 papers that have together received 1.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (13 papers), Long-Term Effects of COVID-19 (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), COVID-19 and Mental Health (4 papers), Viral Infections and Vectors (4 papers), Acute Myeloid Leukemia Research (4 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Infectious Diseases (367 citations), Neurology (263 citations), Applied Microbiology and Biotechnology (29 citations), Critical Care and Intensive Care Medicine (66 citations) and Pathology and Forensic Medicine (228 citations). Vikas Suri has collaborated with scholars based in India and United States. Frequent co-authors include Goverdhan Dutt Puri, Lakshmi Narayana Yaddanapudi, Ashu Rastogi, Pankaj Malhotra, Naresh Sachdeva, Pankaj Malhotra, Anil Bhansali, Sandeep Grover, Savita Kumari and Pankaj Malhotra. Their work appears in journals such as Asian Journal of Psychiatry, The Indian Journal of Medical Research, QJM, Frontiers in Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.